|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Cancer Institute (NCI) |
| Information provided by: | National Cancer Institute (NCI) |
| ClinicalTrials.gov Identifier: | NCT00296075 |
Purpose
RATIONALE: Follow-up of long-term cancer survivors who participated in a clinical trial may help health professionals better understand their disease and determine the long-term effects of treatment.
PURPOSE: This clinical trial is studying long-term cancer survivors to monitor their cancer and determine the effects of previous treatment.
| Condition | Intervention |
|
Long-Term Effects Secondary to Cancer Therapy in Adults Long-Term Effects Secondary to Cancer Therapy in Children Unspecified Childhood Solid Tumor, Protocol Specific Unspecified Adult Solid Tumor, Protocol Specific |
Procedure: complications of therapy assessment/management Procedure: diagnostic imaging Procedure: diagnostic radiology Procedure: observation Procedure: supportive care/therapy |
| MedlinePlus related topics: | Cancer |
| Drug Information available for: | X-Rays |
| Study Type: | Observational |
| Study Design: | Natural History |
| Official Title: | Study of Long-Term Follow-Up in Cancer Survivors Who Were Previously Enrolled on a Center for Cancer Research Protocol |
OBJECTIVES:
OUTLINE: This is a follow-up study.
Patients undergo long-term standard tests and procedures, including laboratory tests, diagnostic radiography, and nuclear medicine studies based on the patient's diagnosis, prior therapy, and supporting clinical information, to follow course of disease and effects of prior therapies until the patient enters another active primary protocol OR follow-up is no longer required at the Center for Cancer Research.
PROJECTED ACCRUAL: A total of 1,000 patients will be accrued for this study.
Eligibility
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
Contacts and Locations| United States, Maryland | |||||
| Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support | |||||
| Bethesda, Maryland, United States, 20892-1182 | |||||
| Principal Investigator: | Frank M. Balis, MD | NCI - Pediatric Oncology Branch |
More Information
Clinical trial summary from the National Cancer Institute's PDQ® database 
  |
| Study ID Numbers: | CDR0000078655, NCI-96-C-0071G |
| First Received: | February 23, 2006 |
| Last Updated: | December 4, 2006 |
| ClinicalTrials.gov Identifier: | NCT00296075 |
| Health Authority: | United States: Federal Government |
|
|